ChunLab Inc
CJ Bioscience, Inc. provides microbiome solutions to address unmet medical needs in South Korea and internationally. The company's platform is Ez-Mx, a bioinformatics-based platform for microbiome data analysis. Its product pipeline includes CJRB-101 that is phase I clinical trial for solid tumors; CJRB-201, CJRB-202, and CJRB-203 for inflammatory bowel diseases; CJRB-302 for Parkinson's diseases… Read more
ChunLab Inc (311690) - Total Liabilities
Latest total liabilities as of September 2025: ₩17.17 Billion KRW
Based on the latest financial reports, ChunLab Inc (311690) has total liabilities worth ₩17.17 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ChunLab Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how ChunLab Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ChunLab Inc Competitors by Total Liabilities
The table below lists competitors of ChunLab Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hankuk Steel Wire Co. Ltd
KQ:025550
|
Korea | ₩160.29 Billion |
|
Jakarta Int Hotels & Dev
JK:JIHD
|
Indonesia | Rp3.10 Trillion |
|
Société des Chemins de Fer et Tramways du Var et du Gard
PA:MLCVG
|
France | €40.57K |
|
Bangkok Ranch PCL
BK:BR
|
Thailand | ฿5.26 Billion |
|
Lumi Gruppen AS
OL:LUMI
|
Norway | Nkr551.59 Million |
|
New Hoong Fatt Holdings Bhd
KLSE:7060
|
Malaysia | RM69.68 Million |
|
Momentum Metropolitan Holdings Ltd
JSE:MTM
|
South Africa | ZAC770.26 Billion |
|
Blue Star Helium Ltd
PINK:BSNLF
|
USA | $14.56 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down ChunLab Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ChunLab Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ChunLab Inc (2017–2024)
The table below shows the annual total liabilities of ChunLab Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩21.85 Billion | +11.31% |
| 2023-12-31 | ₩19.63 Billion | -52.96% |
| 2022-12-31 | ₩41.73 Billion | +46.42% |
| 2021-12-31 | ₩28.50 Billion | -26.69% |
| 2020-12-31 | ₩38.88 Billion | +1246.78% |
| 2019-12-31 | ₩2.89 Billion | +40.32% |
| 2018-12-31 | ₩2.06 Billion | +12.71% |
| 2017-12-31 | ₩1.83 Billion | -- |